Pretreatment tumour necrosis factor-alpha secretions from peripheral blood mononuclear cells of psoriatic patients do not correlate with rapid clinical response: urgent need for prognostic parameters.
Lan
C-C E
CC
Wu
C-S
CS
Chen
G-S
GS
D015415:Biomarkers / Q000097:blood; D000068800:Etanercept; D006801:Humans; D007074:Immunoglobulin G / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007963:Leukocytes, Mononuclear / Q000378:metabolism* / Q000473:pathology; D011379:Prognosis; D011565:Psoriasis / Q000097:blood* / Q000175:diagnosis* / Q000188:drug therapy; D018124:Receptors, Tumor Necrosis Factor / Q000627:therapeutic use; D012720:Severity of Illness Index; D016896:Treatment Outcome; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors / Q000097:blood*
D015415:Biomarkers; D007074:Immunoglobulin G; D007166:Immunosuppressive Agents; D018124:Receptors, Tumor Necrosis Factor; D014409:Tumor Necrosis Factor-alpha; D000068800:Etanercept